How will exercise capacity gain enough respect?

Circulation

Volumn 123, Issue 13, 2011, Pages 1364-1366

  Lauer, Michael S ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

cardiovascular diseases; classification; Editorials; exercise; mortality; risk

Indexed keywords

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; DISEASE SEVERITY; EDITORIAL; EXERCISE; HUMAN; LIFESTYLE MODIFICATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION;

CARDIOVASCULAR DISEASES; EXERCISE; EXERCISE TOLERANCE; HUMANS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 79954633199     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.023218     Document Type: Editorial

References (23)

1. Altman LK. James Fixx: the enigma of heart disease. New York Times. July 24, 1984. http://query.nytimes.com/gst/fullpage.html?res- 9E07E4DB1E39F937A15754C0A962948260. Accessed February 7, 2011.
2. Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation. 1999;99:963-972. (Pubitemid 29094312)
3. Mark DB, Lauer MS. Exercise capacity: the prognostic variable that doesn't get enough respect. Circulation. 2003;108:1534-1536. (Pubitemid 37187775)
4. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS Jr, Blair SN. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547-1553. (Pubitemid 29504048)
5. Diaz LA, Brunken RC, Blackstone EH, Snader CE, Lauer MS. Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol. 2001;37:1558-1564.
6. Hsich E, Gorodeski EZ, Starling RC, Blackstone EH, Ishwaran H, Lauer MS. Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation. 2009;119: 3189-3197.
7. Lauer MS. Discarding logic: 2008 Ancel Keys Memorial Lecture. Circulation. 2009;119:1533-1537.
8. Brotman DJ, Walker E, Lauer MS, O'Brien RG. In search of fewer independent risk factors. Arch Intern Med. 2005;165:138-145.
9. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW. Criteria for evaluation of novel markers of cardiovascular risk: a Scientific Statement from the American Heart Association. Circulation. 2009;119:2408-2416.
10. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303: 1610-1616.
11. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21 3. Ann Intern Med. 2009;150: 65-72.
12. Laukkanen JA, Makikallio TH, Rauramaa R, Kiviniemi V, Ronkainen K, Kurl S. Cardiorespiratory fitness is related to the risk of sudden cardiac death: a population-based follow-up study. J Am Coll Cardiol. 2010;56: 1476-1483.
13. Lauer MS. Risk stratification for sudden cardiac death: a puzzle beyond p values. J Am Coll Cardiol. 2010;56:1484-1485.
14. Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, Drazner MH, de Lemos JA, Berry JD. Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation. 2011;123:1377-1383.
15. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567-1577.
16. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164:1552-1556. (Pubitemid 38970477)
17. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559. (Pubitemid 351831356)
18. Dorn J, Naughton J, Imamura D, Trevisan M. Results of a multicenter randomized clinical trial of exercise and long-term survival in myocardial infarction patients: the National Exercise and Heart Disease Project (NEHDP). Circulation. 1999;100:1764-1769. (Pubitemid 29498381)
19. Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA. 2007;297:2081-2091. (Pubitemid 46798166)
20. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346: 393-403. (Pubitemid 34437694)
21. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439-1450.
22. Rose GA. The Strategy of Preventive Medicine. Oxford, England: Oxford University Press; 1992.
23. Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, McConnachie A, Pringle S, Murdoch D, Dunn F, Oldroyd K, Macintyre P, O'Rourke B, Borland W. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359:482-491.